High-density lipoproteins (HDL) are endogenous nanoparticles involved in the transport and
metabolism of cholesterol, phospholipids, and triglycerides. HDL is well-known as the …

Biopharmaceuticals have emerged to play a vital role in disease treatment and have shown
promise in the rapidly expanding pharmaceutical market due to their high specificity and …

Biomacromolecules are highly promising therapeutic modalities to treat various diseases.
However, they suffer from poor cellular membrane permeability, limiting their access to …

Phase-separating peptides (PSPs) self-assembling into coacervate microdroplets (CMs) are
a promising class of intracellular delivery vehicles that can release macromolecular …

The design of peptide-based subunit vaccine formulations for the direct delivery of tumor
antigen peptides (Aps) to dendritic cells (DCs) localized within draining lymph nodes (DLNs) …

Introduction: Recent trends in drug delivery indicate a steady increase in the use of targeted
therapeutics to enhance the specific delivery of biologically active payloads to diseased …

RNAi therapeutics are believed to be the future of personalized medicine and have shown
promise in early clinical trials. However, many physiological barriers exist in the systemic …

The use of nanoparticle‐stabilized nanocapsules (NPSCs) for the direct cytosolic delivery of
siRNA is reported. In this approach, siRNA is complexed with cationic arginine …

rHDL is a synthesized drug delivery nanoplatform exhibiting excellent biocompatibility,
which possesses most of the advantages of HDL. rHDL shows almost no toxicity and can be …

Codelivery of multiple chemotherapeutics has become a versatile strategy in recent cancer
treatment, but the antagonistic behavior of combined drugs limited their application. We …